Medytox is having difficulty making entry into the Chinese market.

At a presentation on ‘Follow-up regarding Bloomage·Medytox joint venture Medybloom's progress' that was held on the 1st, Bloomage Biotechnology announced that “the company will discontinue the partnership with Medytox and seek opportunities with other botulinum toxin companies."

As one of the largest hyaluronic acid production and marketing enterprises in the world, Bloomage Biotechnology is known for its professional sales power in China's cosmetic surgery market.

With the termination of the partnership, Medytox will now have to seek new venues for entry into the Chinese market without achieving